MGRX — Mangoceuticals Share News
0.000.00%
Last trade - 00:00- $5.43m
- $5.24m
- $0.46m
U.S. STOCKS ON THE MOVE-3M, VF Corp, SiriusXM
U.S. STOCKS ON THE MOVE-Howmet Aerospace, Alaska Air, Arcus Biosciences
U.S. STOCKS ON THE MOVE-BioAge Labs, Piedmont Lithium, United Parcel Service
U.S. STOCKS ON THE MOVE-Boeing, Spirit Airlines, SolarEdge Technologies
MangoRx falls as Lilly sues firm over sale of copycat weight-loss drug
Brief: MangoRx Receives Certificate Of Grant In India For Its Respiratory Illness And Preventive Care Technology Patent
Brief: MangoRX Initiates Efficacy Studies On Patented Technology For Respiratory Illness Prevention
Brief: MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts
Brief: MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets
Brief: MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology
Brief: MangoRx Receives Patent Notice Of Allowance In Japan For Preventive Care Technology Acquired From Intramont Technologies
U.S. STOCKS ON THE MOVE-ProShares Ether, International Business Machines, Alvotech
U.S. STOCKS ON THE MOVE-Durect, Mangoceuticals, International Business Machines
Mangoceuticals surges after co says it will offer its version of GLP-1 drugs
Brief: MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications
Brief: Mangoceuticals Granted 180-Day Extension To Meet Nasdaq Minimum Bid Price Requirement
Brief: MangoRx Mexico Strikes Agreement With Pharmaceutical Manufacturer For Initial Development, Production Of Mango Erectile Dysfunction Products
Brief: Mangoceuticals Inc - On Jan 24 Nasdaq Advised Co That It Has Determined To Grant Co An Extension To Regain Compliance With Listing Rule
Brief: Mangoceuticals To Introduce “Prime” Powered By Kyzatrex